adamantane has been researched along with Hypertrophy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Deng, X; Di, Y; Gao, J; Guo, Y; Huang, X; Liu, L; Sun, S | 1 |
| Cho, MH; Jang, JE; Kim, AR; Kim, BJ; Kim, H; Kim, HJ; Kim, JH; Kim, MO; Kim, SJ; Ko, MS; Koh, EH; Lee, KU; Leem, J; Oh, JS; Park, HS; Woo, CY; Yoo, HJ | 1 |
| Gangadharan Komala, M; Gross, S; Panchapakesan, U; Pollock, C; Zaky, A | 1 |
3 other study(ies) available for adamantane and Hypertrophy
| Article | Year |
|---|---|
Improved endogenous epoxyeicosatrienoic acid production mends heart function via increased PGC 1α-mitochondrial functions in metabolic syndrome.
Topics: Adamantane; Adenosine Triphosphate; Animals; Cardiotonic Agents; Disease Models, Animal; Endothelium; Fibrosis; Heme Oxygenase-1; Hemodynamics; Hypertrophy; Inflammation Mediators; Lauric Acids; Male; Metabolic Syndrome; Mitochondria; Myocardium; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats, Wistar; Up-Regulation | 2018 |
11β-HSD1 reduces metabolic efficacy and adiponectin synthesis in hypertrophic adipocytes.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 3T3-L1 Cells; Adamantane; Adiponectin; Adipose Tissue, White; Animals; Energy Metabolism; Enzyme Inhibitors; Gene Expression Regulation; Glycolysis; Hypertrophy; Lipid Metabolism; Lipotropic Agents; Liver; Male; Mice; Mice, Mutant Strains; Mitochondrial Dynamics; Niacinamide; Non-alcoholic Fatty Liver Disease; Obesity; Oxygen Consumption | 2015 |
Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
Topics: Adamantane; Albuminuria; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fibronectins; Fibrosis; Glomerulonephritis; Hypertrophy; Insulin; Kidney; Male; Mice, Knockout; Nephritis, Interstitial; Nitric Oxide Synthase Type III; Phosphorylation; Signal Transduction; Smad2 Protein; Smad3 Protein; Streptozocin; Transcription Factor RelA; Transforming Growth Factor beta | 2016 |